The FDA has announced mandatory labeling changes for all opioid pain medications to more clearly communicate the risks associated with long-term use, including addiction, overdose, and other serious harms....
New clinical guidance outlines the use of blood-based biomarker tests for Alzheimer’s diagnosis in patients with cognitive impairment, aiming to support more consistent and evidence-based application in...
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
A retrospective study presented at the 2025 American Society for Metabolic and Bariatric Surgery Annual Meeting in Washington, D.C examines the role of gastroesophageal reflux disease, sex, and insurance...
The FDA announced on June 12 that it has approved pembrolizumab for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1.
New research shows stalled childhood vaccine progress, elevated heart risks linked to COVID-19 vaccines in young men, and rising gastrointestinal disorders during the pandemic.
In a large multicenter randomized trial, intrapartum oral sildenafil citrate did not reduce adverse perinatal outcomes related to fetal hypoxia compared with placebo.
A national analysis of county-level measles-mumps-rubella vaccination rates from 2017 to 2024 shows a significant decline following the COVID-19 pandemic, with geographic variation and implications for...
A new national analysis reveals that young adult women (ages 18-25) now binge drink at higher rates than men within the same age range, a reversal of previous trends. While heavy drinking remains more...
